Zhenyu Lin

机构：Union Hospital, University of Shanghai for Science and Technology, Fourth Affiliated Hospital of China Medical University, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology, Southern Medical University, Hubei University, Fuzhou University, China Medical University · ORCID：0000-0002-1733-5806

发表论文 122 篇 · 总被引 1858 次 · h-index 25

代表论文

• Targeting pyroptosis reverses KIAA1199-mediated immunotherapy resistance in colorectal cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 11)
• Efficacy and safety of IBI363 monotherapy or in combination with bevacizumab in patients with advanced colorectal cancer. (2025 · Journal of Clinical Oncology · 被引 6)
• Longitudinal circulating tumor DNA monitoring in predicting response to short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in locally advanced rectal cancer: data from a Phase Ⅲ clinical trial (UNION) (2025 · Cancer Letters · 被引 6)
• Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial (2025 · Nature Communications · 被引 5)
• Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study (2025 · BMC Medicine · 被引 5)
• 1514O First-in-human phase I study of TCR-T therapy targeting KRAS G12V in metastatic solid tumors (2025 · Annals of Oncology · 被引 4)